Literature DB >> 19786760

Treatment of ulcerative colitis in the elderly.

Ashwin N Ananthakrishnan1, David G Binion.   

Abstract

Ulcerative colitis (UC) has a bimodal age distribution, with the majority of patients being diagnosed between the second and fourth decades of life. However, a second peak in diagnosis occurs in older patients and an estimated 15% of patients present after age 65. Caring for older UC patients who have either presented later in life or who have carried an inflammatory bowel disease (IBD) diagnosis for multiple decades may pose additional challenges in management. Recent studies using nationwide administrative databases from the USA have demonstrated that older IBD patients are challenged by worse hospital outcomes. This pattern, seen for both UC and Crohn's disease, demonstrated increased rates of vascular complications (i.e. venous thrombosis), worse post-operative outcomes and increased rates of complicated and prolonged clinical courses compared to younger IBD patients. This article provides an overview of caring for elderly patients with UC, including diagnostic and therapeutic considerations. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19786760     DOI: 10.1159/000228569

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  14 in total

Review 1.  Management of Ulcerative Colitis in the Elderly.

Authors:  Manish P Shrestha; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

Review 2.  Elderly patients and inflammatory bowel disease.

Authors:  Danielle Nimmons; Jimmy K Limdi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

3.  The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study.

Authors:  Chia-Jung Kuo; Kuang-Hui Yu; Lai-Chu See; Cheng-Tang Chiu; Ming-Yao Su; Chen-Ming Hsu; Chang-Fu Kuo; Meng-Jiun Chiou; Jia-Rou Liu; Hung-Wei Wang
Journal:  Dig Dis Sci       Date:  2015-04-03       Impact factor: 3.199

4.  Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.

Authors:  Dipesh Solanky; Darrell S Pardi; Edward V Loftus; Sahil Khanna
Journal:  Inflamm Bowel Dis       Date:  2019-02-21       Impact factor: 5.325

5.  Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases.

Authors:  Gabriella Velonias; Grace Conway; Elizabeth Andrews; John J Garber; Hamed Khalili; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

6.  Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.

Authors:  Amit Desai; Zachary A Zator; Punyanganie de Silva; Deanna D Nguyen; Joshua Korzenik; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2013-02       Impact factor: 5.325

7.  Serious and Opportunistic Infections in Elderly Patients With Inflammatory Bowel Disease.

Authors:  Elissa Lin; Kevin Lin; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-11

Review 8.  Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.

Authors:  Ashwin N Ananthakrishnan; Tamara Donaldson; Karen Lasch; Vijay Yajnik
Journal:  Inflamm Bowel Dis       Date:  2017-06       Impact factor: 5.325

Review 9.  Management of Inflammatory Bowel Disease in the Elderly.

Authors:  Elizabeth S John; Kristina Katz; Mark Saxena; Sita Chokhavatia; Seymour Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2016-09

10.  A clinical review of recent findings in the epidemiology of inflammatory bowel disease.

Authors:  Alexis Ponder; Millie D Long
Journal:  Clin Epidemiol       Date:  2013-07-25       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.